Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
rVSV HIV-1 gag vaccine
Also known as: rVSV vaccine
print preview
bookmark
share with colleague
General Information
Company
Profectus BioSciences Inc.
Description
Recombinant vesicular stomatitis virus (rVSV) vaccine expressing the gag protein of HIV-1 virus
Molecular Target
Mechanism of Action
Vaccine
Latest Stage of Development
Phase I
Indication
HIV / AIDS
Partner
Pfizer Inc.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy